Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples